Prothena | PRTA - Capitalización De Mercado





Capitalización De Mercado Cambio Fecha
Acadia Pharmaceuticals USD 4.33B 537M 2026-06
Akebia Therapeutics USD 427M 297M 2025-12
ALKERMES USD 8.73B 2.85B 2026-06
Alnylam Pharmaceuticals USD 40.19B 3.96B 2026-06
Amgen USD 195.44B 5.55B 2026-06
Biogen USD 31.9B 5B 2026-06
BioMarin Pharmaceutical USD 11.06B 196M 2026-06
Exelixis USD 13.54B 2.65B 2026-06
Immunic USD 64M 23M 2025-12
Incyte USD 22.65B 3.92B 2026-06
Ionis Pharmaceuticals USD 13.1B 642M 2026-06
MacroGenics USD 184M 82M 2026-03
Nektar Therapeutics USD 2.12B 1.26B 2026-03
Neurocrine Biosciences USD 16.95B 3.7B 2026-06
Prothena USD 516M 2M 2026-03
Regeneron Pharmaceuticals USD 65.37B 16.31B 2026-06
Ultragenyx Pharmaceutical USD 3.29B 1.23B 2026-06
Vertex Pharmaceuticals USD 126.07B 12.49B 2026-06